1 study found for:    1230.14
Show Display Options
Rank Status Study
1 Recruiting Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: placebo;   Drug: volasertib;   Drug: low dose cytarabine

Indicates status has not been verified in more than two years